Edition:
United Kingdom

Spark Therapeutics Inc (ONCE.OQ)

ONCE.OQ on NASDAQ Stock Exchange Global Select Market

84.97USD
13 Jul 2018
Change (% chg)

$-4.30 (-4.82%)
Prev Close
$89.27
Open
$88.98
Day's High
$89.12
Day's Low
$83.69
Volume
148,831
Avg. Vol
206,117
52-wk High
$96.51
52-wk Low
$41.06

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 15.68 -1.252
FY 2017 Dec '17 7.41 -1.745
Sep '17 1.90 -1.898
Jun '17 1.48 -2.401
Mar '17 1.27 -1.699
FY 2016 Dec '16 16.30 -1.205
Sep '16 1.30 -1.072
Jun '16 1.29 -1.044
Mar '16 1.29 -0.954
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 16 38.23 56.56 10.32 1.30
Quarter Ending Dec-18 16 29.85 86.40 8.69 1.30
Year Ending Dec-18 18 133.80 253.00 44.90 120.42
Year Ending Dec-19 21 135.83 220.00 42.10 311.38
Earnings (per share)
Quarter Ending Sep-18 19 -0.84 -0.03 -1.68 -1.82
Quarter Ending Dec-18 19 -1.16 0.08 -1.83 -1.81
Year Ending Dec-18 20 -3.30 0.05 -5.78 -4.65
Year Ending Dec-19 21 -4.18 -2.23 -7.98 -0.39
LT Growth Rate (%) 1 17.00 17.00 17.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.48 32.76
P/E High - Last 5 Yrs. -- 298.85 45.44
P/E Low - Last 5 Yrs. -- 91.59 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 153.83 112.69 5.73
Price to Book (MRQ) 11.96 14.09 5.45
Price to Tangible Book (MRQ) 13.80 14.67 7.05
Price to Cash Flow (TTM) -- 72.72 23.29
% Owned Institutions 83.26 14.42 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.70 5.22
Payout Ratio(TTM) -- 16.38 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 15.10 408.74 8.01
Sales (TTM) vs TTM 1 Yr. Ago -3.39 80.05 5.64
Sales - 5 Yr. Growth Rate -- 32.09 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -129.91 29.06 20.60
EPS (TTM) vs TTM 1 Yr. Ago -116.29 -- --
EPS - 5 Yr. Growth Rate -- 39.56 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.05 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.92 2.22
Current Ratio (MRQ) 6.09 5.50 3.03
LT Debt to Equity (MRQ) 0.47 25.57 12.39
Total Debt to Equity (MRQ) 0.60 27.28 16.72
Interest Coverage (TTM) -- -101.33 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.25 54.37
Gross Margin - 5 Yr. Avg. -- 50.67 52.17
EBITD Margin (TTM) -816.79 -- --
EBITD - 5 Yr. Avg -- -588.18 10.81
Operating Margin (TTM) -984.26 -734.89 4.57
Operating Margin - 5 Yr. Avg. -- -609.81 6.23
Pre-Tax Margin (TTM) -973.11 -708.96 5.43
Pre-Tax Margin - 5 Yr. Avg. -- -613.30 6.67
Net Profit Margin (TTM) -962.76 -710.36 1.73
Net Profit Margin - 5 Yr. Avg. -- -616.33 2.94
Effective Tax Rate (TTM) -- 23.27 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.59 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 95,602 23,066,163 860,414,722
Net Income/Employee (TTM) -920,417 3,124,085 101,211,891
Receivable Turnover (TTM) 6.52 20.78 5.87
Inventory Turnover (TTM) -- 2.48 3.41
Asset Turnover (TTM) 0.06 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.26 0.33 11.14
Return on Assets - 5 Yr. Avg. -- 3.75 12.40
Return on Investment (TTM) -61.15 2.29 14.61
Return on Investment - 5 Yr. Avg. -- 2.93 16.14
Return on Equity (TTM) -63.88 3.86 16.34
Return on Equity - 5 Yr. Avg. -- 4.40 17.40
  1 Year 3 Year 5 Year
Sales % -8.52 -- --
EPS (TTM) % -104.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Spark Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.35 2.68 99 53
13 Week 41.42 34.53 99 66
26 Week 71.05 58.05 99 79
52 Week 44.55 22.52 99 52
YTD 75.23 53.89 99 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 250
Total Shares Held: 39,749,708
3 Mo. Net Change: 83,642
# New Positions: 3
# Closed Positions: 1
# Increased Positions: 16
# Reduced Positions: 10
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.